Clinical Pharmacy

CRISA pharmacy comply with all relevant National and International legislative and regulatory requirements. Quality Control Management of Investigational Medical Product (IMP) at CRISA is a process of establishing and ensuring the quality of pharmacy processes, data, and documentation associated with clinical trials activities. Processes to be taken to ensure quality control at the pharmacy are defined in our Pharmacy Standard Operating Procedures (SOPs).